Education
About Us
Working with TipRanks
Follow Us
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
Total Valuation
Aarti Drugs Limited has a market cap or net worth of ₹33.38B. The enterprise value is ₹52.66B.
Market Cap₹33.38B
Enterprise Value₹52.66B
Share Statistics
Aarti Drugs Limited has 91,270,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,270,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarti Drugs Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Aarti Drugs Limited is ―. Aarti Drugs Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Aarti Drugs Limited had revenue of 25.09B and earned 1.71B in profits. Earnings per share was 18.56.
Revenue25.09B
Gross Profit3.51B
Operating Income2.78B
Pretax Income2.36B
Net Income1.71B
EBITDA3.20B
Earnings Per Share (EPS)18.56
Cash Flow
In the last 12 months, operating cash flow was 505.40M and capital expenditures 0.00, giving a free cash flow of 505.40M billion.
Operating Cash Flow505.40M
Free Cash Flow505.40M
Free Cash Flow per Share5.54
Dividends & Yields
Aarti Drugs Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.27%
Dividend Per Share₹1
Dividend Yield0.27%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.08
52-Week Price Change-26.89%
50-Day Moving Average361.94
200-Day Moving Average457.44
Relative Strength Index (RSI)56.30
Average Volume (3m)17.96K
Important Dates
Aarti Drugs Limited upcoming earnings date is May 16, 2025, TBA Not Confirmed.
Last Earnings DateJan 29, 2025
Next Earnings DateMay 16, 2025
Ex-Dividend DateFeb 04, 2025
Financial Position
Aarti Drugs Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Aarti Drugs Limited has paid 639.37M in taxes.
Income Tax639.37M
Effective Tax Rate―
Enterprise Valuation
Aarti Drugs Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Aarti Drugs Limited has ₹207.70M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹207.70M billion.
Cash & Marketable Securities₹207.70M
Total Debt₹0.00
Net Cash-₹207.70M
Net Cash Per Share-₹2.28
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Aarti Drugs Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―